Screening of a HUVEC cDNA library with transplant-associated coronary artery disease sera identifies RPL7 as a candidate autoantigen associated with this disease

Clinical and Experimental Immunology

Volumn 126, Issue 1, 2001, Pages 173-179

  Linke, A T ^a   Marchant, B ^a   Marsh, P ^b   Frampton, G ^c   Murphy, J ^d   Rose, M L ^a  

^a HAREFIELD HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF WOLVERHAMPTON   (United Kingdom)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Antibodies; Cardiac; Chronic rejection; Transplantation

Indexed keywords

AUTOANTIGEN; BETA TRANSDUCIN; COMPLEMENTARY DNA; GENE PRODUCT; HYBRID PROTEIN; LYSINE TRANSFER RNA LIGASE; PROTEIN TANK; RIBOSOMAL PROTEIN L7; RIBOSOMAL PROTEIN L9; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL LINE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA LIBRARY; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; GENE CONSTRUCT; HEART TRANSPLANTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY; MALE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SEROPREVALENCE; SERUM;

ADULT; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNE DISEASES; CORONARY ARTERIOSCLEROSIS; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE LIBRARY; HEART TRANSPLANTATION; HUMANS; KINETICS; MALE; MIDDLE AGED; RIBOSOMAL PROTEINS; UMBILICAL VEINS;

EID: 0034777037     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2001.01654.x     Document Type: Article

References (41)

1. Histopathology of graft coronary disease
2. Estrogen effects on insulin-like growth factor-I (IGF-I)-induced cell proliferation and IGF-I expression in native and allograft vessels
3. Role of smooth-muscle cells and macrophages in cardiac allograft arteriosclerosis in rabbits
4. Remodeling of autologous saphenous vein grafts. The role of perivascular myofibroblasts
5. Local events in graft rejection
6. Antibody to CD18 reduces neutrophil and T lymphocyte infiltration and vascular cell adhesion molecule-1 expression in cardiac rejection
7. Cardiac allograft vasculopathy: A review
8. The pathogenesis of atherosclerosis
9. The pathogenesis of atherosclerosis
10. Immunopathology of cardiac transplant rejection
11. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: Efficacy of novel therapeutic approaches
12. Vascular smooth muscle cells and neointimal hyperplasia in chronic transplant rejection
13. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease
14. Effect of anti-HLA antibodies on the long-term survival of heart and kidney allografts
15. The role of anti-HLA antibodies in heart transplantation
16. Reduction of cellular rejection and increase in longer-term survival after heart transplantation after HLA-DR matching
17. Influence of acute rejection episodes, HLA matching, and donor/recipient phenotype on the development of 'early' transplant-associated coronary artery disease
18. Anti-endothelial antibodies and coronary artery disease after cardiac transplantation
19. Antiendothelial antibodies after heart transplantation: The accelerating factor in transplant-associated coronary artery disease?
20. Characterization of endothelial antigens associated with transplant-associated coronary artery disease
21. A new enzyme-linked immunosorbent assay to measure anti-endothelial antibodies after cardiac transplantation demonstrates greater inhibition of antibody formation by tacrolimus compared with cyclosporine
22. Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation
23. Anti-cell surface endothelial antibodies in sera from cardiac and kidney transplant recipients: Association with chronic rejection
24. High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis
25. Prevalence and characterization of novel pANCA, antibodies to the high mobility group non-histone chromosomal proteins HMG1 and HMG2, in systemic rheumatic diseases
26. Prevalence and characterization of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) directed against HMG1 and HMG2 in ulcerative colitis (UC)
27. Secretion and binding of HMG1 protein to the external surface of the membrane are required for murine erythroleukemia cell differentiation
28. Autoantibodies against eukaryotic protein L7 in patients suffering from systemic lupus erythematosus and progressive systemic sclerosis: Frequency and correlation with clinical, serological and genetic parameters
29. Premature atherosclerosis in systemic lupus erythematosus
30. A map of 75 human ribosomal protein genes
31. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
32. A receptor for phosphatidylserine-specific clearance of apoptotic cells
33. Antiribosomal P0 protein antibodies react with the surface of human umbilical vein endothelial cells
34. Human lysyl-tRNA synthetase accepts nucleotide 73 variants and rescues escherichia coli double-defective mutant
35. Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein
36. Physical linkage of a guanine nucleotide-binding protein-related gene to the chicken major histocompatibility complex
37. Identification of a transcript that is down-regulated in senescent human fibroblasts. Cloning, sequence analysis, and regulation of the human L7 ribosomal protein gene
38. Structural organization and chromosomal localization of the human ribosomal protein L9 gene
39. Auto-antibodies to the ribosomal P proteins react with a plasma membrane-related target on human cells
40. Autoantibodies to ribosomal P proteins penetrate into live hepatocytes and cause cellular dysfunction in culture
41. De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process